Kamada KMDA
NASDAQ KMDA
$8.31 +0.11 (+1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kamada (KMDA) Return on Invested Capital [ROIC] (2013 - 2026)

Updated

Kamada (KMDA) recorded Return on Invested Capital [ROIC] of 10.20% in the quarter ended Jun 30, 2026, up 0.72 percentage points from 9.48% a year earlier and up 0.95 percentage points from the prior quarter.

Analysis

Kamada (KMDA) Return on Invested Capital [ROIC] (2013 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Kamada reported Return on Invested Capital [ROIC] of 9.56%, up 1.98 percentage points from the prior year.

  • Annual Return on Invested Capital [ROIC] has increased for four straight years, though with a five-year change of -1.72 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Return on Invested Capital [ROIC] came in at 7.59% in the year ended Dec 31, 2024 (+3.30 pp), 4.29% in the year ended Dec 31, 2023 (+2.11 pp), 2.18% in the year ended Dec 31, 2022 (+2.55 pp) and -0.37% in the year ended Dec 31, 2021 (-11.66 pp).
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Return on Invested Capital [ROIC] since the quarter ended Sep 30, 2020.
  • On a year-over-year basis, Return on Invested Capital [ROIC] has increased for 14 consecutive quarters, with an average year-over-year change of +2.37 percentage points over the last eight quarters.
  • The year-over-year gain in Return on Invested Capital [ROIC] has ranged between 0.31 percentage points (the quarter ended Mar 31, 2026) and 10.10 percentage points (the quarter ended Jun 30, 2023) over the last five years.
  • Per Business Quant, the preceding three quarters came in at 9.25% (quarter ended Mar 31, 2026), 9.46% (quarter ended Dec 31, 2025) and 10.18% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Kamada 479.37 Mn 188.43 Mn 22.47 Mn 10.20%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.20%
Mar 31, 2026 9.25%
Dec 31, 2025 9.46%
Sep 30, 2025 10.18%
Jun 30, 2025 9.48%
Mar 31, 2025 8.94%
Dec 31, 2024 7.50%
Sep 30, 2024 6.72%
Jun 30, 2024 6.37%
Mar 31, 2024 5.26%
Dec 31, 2023 3.85%
Sep 30, 2023 4.66%
Jun 30, 2023 4.36%
Mar 31, 2023 2.21%
Dec 31, 2022 2.22%
Sep 30, 2022 -2.56%
Jun 30, 2022 -5.74%
Mar 31, 2022 -1.45%
Dec 31, 2020 9.98%
Sep 30, 2020 11.97%
API Access

Kamada Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=KMDA&period=max&api_key=YOUR_API_KEY